These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21381276)

  • 1. [Risk stratification tools for evaluating thromboembolic risk in atrial fibrillation].
    Ouardiri Y; Marti C; Carballo S; Garin N
    Rev Med Suisse; 2011 Feb; 7(280):313-6, 318-9. PubMed ID: 21381276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke prevention in atrial fibrillation.
    Mohammed I; Mohmand-Borkowski A; Burke JF; Kowey PR
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):73-85. PubMed ID: 22193836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Which patients with atrial fibrillation need anticoagulation?].
    Despotovic SF; Siewe S; Keta A
    Rev Med Suisse; 2010 Sep; 6(264):1816-8, 1820. PubMed ID: 20964018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
    Pamukcu B; Lane DA; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1703-10. PubMed ID: 21108552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly].
    Poli D; Grifoni E
    Recenti Prog Med; 2011 Jan; 102(1):23-7. PubMed ID: 21516668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of atrial fibrillation in dialyzed patients: the role of oral anticoagulants. The cardiologist's point of view].
    Lucreziotti S; Lombardi F
    G Ital Nefrol; 2010; 27(3):222-9. PubMed ID: 20540014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of atrial fibrillation burden in assessing thromboembolic risk.
    Zimetbaum P; Waks JW; Ellis ER; Glotzer TV; Passman RS
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1223-9. PubMed ID: 25516580
    [No Abstract]   [Full Text] [Related]  

  • 12. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving stroke risk stratification in atrial fibrillation.
    Lip GY; Halperin JL
    Am J Med; 2010 Jun; 123(6):484-8. PubMed ID: 20569748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of atrial fibrillation.
    Watson T; Lip GY
    Herz; 2006 Dec; 31(9):849-56. PubMed ID: 17180647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.